Two students in the Dual BA Program Between Columbia University and Sciences Po were recently awarded prestigious scholarships: Eric Jiefei Deng ‘20 received the Critical Languages Scholarship (CLS) and Isabel O’Brien ‘21 received Henri de Castries Scholarship.
Sixty-one graduates of the Dual BA Program Between Columbia University and Sciences Po—the largest number since the Program began—were among the 585 graduates honored at the GS Class Day ceremony on Monday, May 15, 2017.
Nur Arafeh '13 was recently selected as a 2017 Rhodes Scholar, and will pursue a Doctor of Philosophy degree in international development at Oxford University next fall. Arafeh is one of just three students who were selected from the region of Syria, Jordan, Lebanon, and Palestine (SJLP) this year, which is the first year that the Rhodes Trust has awarded scholarships in that region.
This year, the Dual BA Program Between Columbia University and Sciences Po will welcome 68 new students, its largest cohort to date. These students will embark on two years of study at one of Sciences Po’s three regional campuses – Reims, Menton, or Le Havre – followed by two years at Columbia University’s Morningside campus in New York City.
Dual BA Program student Luca Springer ’16 has been selected as a 2016 Rhodes Scholar. He is one of only 89 recipients of this prestigious award worldwide, and will pursue a Master of Public Policy degree at Oxford University this fall.
This fall, the Dual BA Program Between Columbia University and Sciences Po will welcome the 2015 entering class. 67 students will begin their studies at one of three Sciences Po campuses in France—Le Havre, Menton, or Reims—where they will spend two years studying social sciences devoted to a particular region of the world with a heavy linguistic and cultural focus.
Dual Degree student Daniel Nothaft is a member of the band Chill Beenz, a group of musicians and friends who donated 100 percent of the sales from their most recent album to the Cholangiocarcinoma Foundation, which works to support individuals diagnosed with bile duct cancer.